210 related articles for article (PubMed ID: 14747215)
1. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.
Colagiuri S; Hussain Z; Zimmet P; Cameron A; Shaw J;
Diabetes Care; 2004 Feb; 27(2):367-71. PubMed ID: 14747215
[TBL] [Abstract][Full Text] [Related]
2. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
[TBL] [Abstract][Full Text] [Related]
3. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
4. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
[TBL] [Abstract][Full Text] [Related]
5. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
[TBL] [Abstract][Full Text] [Related]
6. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
[TBL] [Abstract][Full Text] [Related]
7. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
8. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
[TBL] [Abstract][Full Text] [Related]
9. Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study.
Doerr R; Hoffmann U; Otter W; Heinemann L; Hunger-Battefeld W; Kulzer B; Klinge A; Lodwig V; Amann-Zalan I; Sturm D; Tschoepe D; Spitzer SG; Stumpf J; Lohmann T; Schnell O
Diabetologia; 2011 Nov; 54(11):2923-30. PubMed ID: 21773683
[TBL] [Abstract][Full Text] [Related]
10. Glycated haemoglobin as a screening test for abnormal glucose homeostasis in childhood obesity.
Kumbhojkar A; Saraff V; Nightingale P; Högler W
Diabet Med; 2020 Feb; 37(2):356-361. PubMed ID: 31782826
[TBL] [Abstract][Full Text] [Related]
11. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
12. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
13. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
[TBL] [Abstract][Full Text] [Related]
14. Can a screening programme for diabetes be applied to another population?
Glümer C; Borch-Johnsen K; Colagiuri S
Diabet Med; 2005 Sep; 22(9):1234-8. PubMed ID: 16108854
[TBL] [Abstract][Full Text] [Related]
15. A1C cut points to define various glucose intolerance groups in Asian Indians.
Mohan V; Vijayachandrika V; Gokulakrishnan K; Anjana RM; Ganesan A; Weber MB; Narayan KM
Diabetes Care; 2010 Mar; 33(3):515-9. PubMed ID: 19903752
[TBL] [Abstract][Full Text] [Related]
16. Screening for type 2 diabetes: literature review and economic modelling.
Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
18. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
19. A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women.
Lidfeldt J; Nerbrand C; Samsioe G; Scherstén B; Agardh CD
Eur J Epidemiol; 2001; 17(10):943-51. PubMed ID: 12188015
[TBL] [Abstract][Full Text] [Related]
20. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.
Manley SE; Sikaris KA; Lu ZX; Nightingale PG; Stratton IM; Round RA; Baskar V; Gough SC; Smith JM
Diabet Med; 2009 Feb; 26(2):115-21. PubMed ID: 19236612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
